The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimorus Inv. Regulatory News (PRIM)

Share Price Information for Primorus Inv. (PRIM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.75
Bid: 3.50
Ask: 4.00
Change: 0.00 (0.00%)
Spread: 0.50 (14.286%)
Open: 3.75
High: 3.75
Low: 3.75
Prev. Close: 3.75
PRIM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

2 Sep 2022 14:00

RNS Number : 1488Y
Primorus Investments PLC
02 September 2022
 

Primorus Investments plc

 

("Primorus" or the "Company")

 

Interim Results for the six months ended 30 June 2022

 

Primorus Investments plc (AIM: PRIM) is pleased to announce its unaudited interim results for the six months ended 30 June 2022.

 

Overview

 

The last six months have been a difficult time for the capital markets with the war in Ukraine, rising inflation and political instability. With greater uncertainties, investors are more cautious which has had a negative effect on the asset valuations for some of Primorus' investments. Despite the level of unrealised losses in the first 6 months of this year, we remain confident in the longer-term prospects of these investments.

 

Notwithstanding the current market turbulence, Fresho Pty Ltd ("Fresho") successfully raised AUD$12m of new equity capital at $0.90 per share in April 2022. This represents a premium of 55% to the last investment made by Primorus in March 2021.

 

Primorus also invested £1,000,000 in AIM listed Clean Power Hydrogen ("CPH2"). CPH2 is a manufacturer of the membrane-free electrolyser (MFE) which is used to create hydrogen and medical grade oxygen. Since the original investment CPH2 has secured a 20-year licensing agreement with GHFG Ltd for the construction of 2 gigawatts of MFE electrolysers over a period of up to 20 years.

 

In addition, Alteration Earth PLC, a special purpose acquisition company which Primorus holds approximately 28% of the issued share capital, listed on the Main Market of the London Stock Exchange shortly after the period end. 

 

Financial Results

 

The operating loss for the six months to 30 June 2022 was £847,000 (30 June 2021: £115,000 loss). The net loss after tax was £847,000 (30 June 2021: £115,000 loss).

 

Total assets, including cash, at 30 June 2022 amounted to £8.23 million (30 June 2021: £9.17 million).

 

Outlook

 

The Board remains confident that significant opportunities exist for the Company going forward. The Board is continually seeking new investment opportunities whilst also monitoring its existing investments to determine when it is appropriate to materialise them.

 

The Board has screened several exciting opportunities within the period and looks forward to making further investments in the near term.

 

We look forward to updating shareholders as and when our existing investments mature, and new investments present themselves.

 

The Directors would like to take this opportunity to thank our shareholders and consultants for their continued support.

Rupert Labrum Chairman

2nd September 2022

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Caution regarding forward looking statements

 

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors. While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting the Company will be those that it anticipates.

 

 

For further information please contact:

 

Primorus Investments plc

Matthew Beardmore, Chief Executive Officer

 

+44 (0)20 8154 7907

 

Nominated Adviser

Cairn Financial Advisers LLP

James Caithie / Sandy Jamieson

 

+44 (0) 20 7213 0880

 

 

 

 

Unaudited Condensed Company Statement of Comprehensive Income

for the six months ended 30 June 2022

 

6 months to

6 months to

Year to

30 June

2022

30 June

2021

31 December

2021

Unaudited

Unaudited

Audited

Not es

£'000

£'000

£'000

Continuing operations

Revenue

Investment income

52

48

141

Realised gain/(loss) on disposal of financial  investments

(300)

107

323

Unrealised gain/(loss) on market value movement of financial investments

(500)

(21)

19

Total (losses)/gains on financial investments

(748)

134

483

Share based payments

(63)

(13)

(13)

Operating costs

(36)

(236)

(405)

 

Impairment of financial investments

 

-

 

-

 

(106)

(Loss)/Profit before tax

(99)

(115)

(41)

Taxation

-

-

150

(Loss)/Profit for the period attributable to equity shareholders of the company

(847)

(115)

109

 

Other comprehensive income

-

-

-

Total Comprehensive Income for the year attributable to equity shareholders of the company

 

(847)

 

(115)

 

109

 

Profit/(Loss) per share:

Basic profit/(loss) per share (pence)

2

(0.6)

(0.08)

0.078

Diluted profit/(loss) per share (pence)

2

(0.6)

(0.08)

0.072

 

 

Unaudited Condensed Company Statement of Financial Position

as at 30 June 2022

 

30 June

2022

30 June

2021

31 December

2021

Unaudited

Unaudited

Audited

Note s

£'000

£'000

£'000

ASSETS

Non-current assets

Financial investments

7,742

6,998

7,533

7,742

6,998

7,533

 

Current assets

Investments

20

812

511

Trade and other receivables

39

14

5

Cash and cash equivalents

427

1,346

941

486

2,172

1,457

Total assets

8,228

9,170

8,990

 

EQUITY

Equity attributable to equity holders of the parent

Share capital

280

15,391

280

Share premium account

-

35,296

-

Share based payment reserve

76

13

13

Retained earnings

7,769

(42,016)

8,616

Total equity

8,125

8,684

8,909

LIABILITIES

Current liabilities

Trade and other payables

70

39

44

Corporation tax

33

447

37

Total liabilities

103

486

81

Total equity and liabilities

8,228

9,170

8,990

Unaudited Condensed Company Statement of Changes in Equity

for the six months ended 30 June 2022

 

 

Share capital

 

Share premium

Share based

payment reserve

 

Retained earnings

Total attributable

to owners of parent

 

£'000

£'000

£'000

£'000

£'000

Unaudited

 

 

 

 

 

Balance at 31 December 2020

15,391

35,296

-

(41,901)

8,786

 

Profit for the period

 

-

 

-

 

-

 

109

 

109

Total comprehensive income for the

period

 

-

 

-

 

-

 

109

 

109

Issuance of share options

 

Shares cancelled during the year

 

 

-

 

(15,111)

 

 

-

 

(35,296)

 

13

 

-

 

-

 

(50,408)

 

13

 

-

 

 

Balance at 31 December 2021

 

280

 

-

 

13

 

8,616

 

8,909

 

Loss for the period

 

-

 

-

 

-

 

(847)

 

(847)

Total comprehensive income for the period

 

-

 

-

 

-

 

(847)

 

(847)

 

Share based payment

 

 

 

63

 

-

 

63

Balance at 30 June 2022

280

-

76

7,769

8,125

 

 

 

Unaudited Condensed Company Statement of Cash Flows

for the six months ended 30 June 2022

 

 

6 months to

6 months to

Year

to

30-Jun-22

30-Jun-21

31-Dec-21

Unaudited

Unaudited

Audited

£'000

£'000

£'000

Cash flows from operating activities

Operating profit/(loss)

(847)

(115)

109

Adjustments for:

(Profit)/Loss on disposal of financial investments

300

(107)

(323)

Fair value movement on listed investments

500

21

(19)

Impairment provision on unlisted investments

-

-

106

Decrease/(increase) in trade and other  receivables

(34)

(11)

(3)

Increase/(decrease) in trade and other payables

26

(16)

(11)

Foreign exchange loss/(gain)

(132)

81

55

Interest income on investments

(52)

(48)

(142)

Share based payment

63

13

13

Income tax (credit)

-

-

(150)

 

(176)

(182)

(365)

 

Income taxes paid

 

(4)

 

-

 

(260)

 

Net cash used in operating activities

(180)

(182)

(625)

Cash flows from investing activities

Disposal proceed from sale of financial investments

 

3,026

 

2,533

 

3,474

Payment for financial investments

(3,360)

(5,565)

(6,468)

Net cash (used in) investing activities

(334)

(3,032)

(2,994)

Net change in cash and cash equivalents

(514)

(3,214)

(3,619)

 

Cash and cash equivalents at beginning of period

 

941

 

4,560

 

4,560

Cash and cash equivalents at end of period

427

1,346

941

 

 

Notes to the condensed unaudited interim financial statements

 

1. General Information

 

The condensed interim financial information for the 6 months to 30 June 2022 does not constitute statutory accounts for the purposes of Section 434 of the Companies Act 2006 and has not been audited or reviewed. No statutory accounts for the period have been delivered to the Registrar of Companies.

 

The condensed interim financial information in respect of the year ended 31 December 2021 has been produced using extracts from the statutory accounts for that period. Consequently, this does not constitute the statutory information (as defined in section 434 of the Companies Act 2006) for the year ended 31 December 2021, which was audited. The statutory accounts for this period have been filed with the Registrar of Companies. The auditors' report was unqualified and did not contain a statement under Sections 498 (2) or 498 (3) of the Companies Act 2006.

 

The auditor's report was approved by the Directors on 10th June 2022 and is available on the Company's website at www.primorusinvestments.com.

 

2. Basis of preparation and accounting

 

The financial information has been prepared on the historical cost basis. The Company's business activities, together with the factors likely to affect its future development, performance and position are set out in the Chairman's Statement. This statement also includes a summary of the Company's financial position and its cash flows.

 

The financial statements have been prepared in accordance with the Companies Act 2006 and UK-adopted international accounting standards (UK-adopted IAS) and related interpretations. As permitted, this does not include IAS 34 "Interim Financial Reporting". This condensed set of financial statements has been prepared applying the accounting policies that were applied in the preparation of the Company's published financial statements for the year ended 31st December 2021. As these interim financial statements do not include all of the information or disclosures required in the annual financial statements they should be read in conjunction with the Company's 2021 annual financial statements.

 

3. Earnings per share

 

Earnings per ordinary share has been calculated using the weighted average number of shares in issue during the period. The weighted average number of equity shares in issue was 139,830,968. IAS 33 requires presentation of diluted EPS when a company could be called upon to issue shares that would decrease earnings per share or increase the loss per share.

 

Six months

to

Six months

to

Year ended

30 June

2022

30 June

2021

31 December

2021

(Unaudited)

(Unaudited)

(Audited)

restated

(£'000)

(£'000)

(£'000)

Net profit/(loss) attributable to equity holders of

  the company

(847)

(115)

109

Weighted average number of shares

139,830,968

139,830,968

139,830,968

Weighted average number of diluted shares

139,830,968

151,830,968

151,830,968

Basic (loss)/profit per share (pence)

(0.6)

(0.08)

0.078

Diluted (loss)/profit per share (pence)

(0.6)

(0.08)

0.072

 

 

4. Events after the reporting date

 

Primorus was informed on the 31 August 2022 that the board of Nomad Energy has concluded that the company is no longer solvent. An insolvency specialist is in the process of being appointed and the company will be liquidated.

 

Primorus sold 228 ordinary shares of £1.00 each of Supernatural Food Limited (company number 10441682) for an aggregate sale price of £39,918.24. The funds were received by Primorus on the 05 July 2022. Primorus is working with the company to try and secure a buyer for the remaining shares.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BDGDCCDGDGDD
Date   Source Headline
18th Jan 200811:55 amRNSDirector/PDMR Shareholding
18th Jan 200811:54 amRNSHolding(s) in Company
18th Jan 200811:54 amRNSHolding(s) in Company
18th Jan 200811:52 amRNSHolding(s) in Company
8th Jan 20087:00 amRNSDisposal
14th Dec 20077:00 amRNSShare Capital Reduction & EGM
30th Oct 20078:05 amRNSHolding(s) in Company
30th Oct 20078:00 amRNSHolding(s) in Company
25th Oct 20074:00 pmRNSTrading Update
28th Sep 20077:06 amRNSInterim Results
12th Sep 20074:38 pmRNSAppointment
31st Aug 20078:00 amRNSChange of Adviser
30th Aug 20075:26 pmRNSHolding(s) in Company
23rd Aug 200711:20 amRNSTotal Voting Rights
22nd Aug 20075:22 pmRNSHolding(s) in Company
21st Aug 20073:39 pmRNSAIM Rule 26
16th Aug 20074:14 pmRNSAGM Result & New Chairman
9th Aug 20072:41 pmRNSRe Board Appointments
25th Jul 20073:18 pmRNSHolding(s) in Company
25th Jul 20077:00 amRNSBoard Changes and AGM Notice
24th Jul 20079:00 amRNSHolding(s) in Company
19th Jul 20074:23 pmRNSHolding(s) in Company
19th Jul 20072:51 pmRNSDirector/PDMR Shareholding
3rd Jul 20072:09 pmRNSResult of EGM
26th Jun 200711:00 amRNSAnnual Report and Accounts
26th Jun 20077:02 amRNSSpeculation Response
25th Jun 20077:03 amRNSResponse to Requisition
14th Jun 200712:00 pmRNSHolding(s) in Company
12th Jun 20075:40 pmRNSNotice of EGM
23rd May 20075:40 pmRNSResponse to Media
23rd May 20078:00 amRNSRequisition of EGM
15th Mar 20077:03 amRNSPreliminary Results
22nd Feb 20079:45 amRNSHolding(s) in Company
22nd Feb 20079:34 amRNSHolding(s) in Company
21st Dec 200610:57 amRNSTotal Voting Rights
17th Oct 200612:52 pmRNSDirectorate Change
14th Sep 20065:44 pmRNSHolding(s) in Company
14th Sep 20065:03 pmRNSHolding(s) in Company
9th Jun 200610:13 amRNSDirector/PDMR Shareholding
7th Jun 20063:35 pmRNSDirector/PDMR Shareholding
16th May 200610:05 amRNSAGM Statement
24th Apr 20062:27 pmRNSRelated Party Transaction
29th Mar 20062:19 pmRNSDirector/PDMR Shareholding
22nd Mar 20065:57 pmRNSDirector Shareholding
20th Mar 20067:02 amRNSFinal Results
8th Mar 20067:02 amRNSDirectorate Change
26th Jan 20064:19 pmRNSHolding(s) in Company
25th Jan 200611:02 amRNSSAR 3 - CSS Stellar plc
25th Jan 200610:06 amRNSHolding(s) in Company
19th Jan 20069:00 amRNSTreasury Stock

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.